HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Takahashi Selected Research

Fluvoxamine (Luvox)

6/2008Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
1/2003Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine.
12/2002Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder.
10/2002No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment.
3/2002Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial.
2/2002Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.
1/2002Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Takahashi Research Topics

Disease

31Parkinson Disease (Parkinson's Disease)
01/2018 - 03/2002
30Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2018 - 06/2003
27Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 02/2002
23Neoplasms (Cancer)
03/2019 - 02/2002
22Schizophrenia (Dementia Praecox)
09/2022 - 03/2002
22Multiple System Atrophy
11/2019 - 03/2002
22Dementia (Dementias)
10/2017 - 03/2002
17Lewy Body Disease (Lewy Body Dementia)
01/2018 - 07/2002
15Alzheimer Disease (Alzheimer's Disease)
08/2015 - 06/2002
14Synucleinopathies
01/2018 - 07/2002
13Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2016 - 06/2003
11Major Depressive Disorder (Major Depressive Disorders)
01/2009 - 01/2002
9Infections
01/2020 - 05/2002
9Glioma (Gliomas)
03/2019 - 11/2005
7Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2018 - 04/2007
7Tauopathies
12/2015 - 08/2003
7Frontotemporal Dementia (Semantic Dementia)
12/2013 - 04/2004
6Exercise-Induced Allergies
10/2016 - 12/2009
6Sepsis (Septicemia)
01/2015 - 12/2002
5Human Influenza (Influenza)
01/2018 - 08/2003
5Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
10/2017 - 06/2002
5Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy)
02/2016 - 11/2002
5Motor Neuron Disease (Primary Lateral Sclerosis)
02/2014 - 10/2009
5Inflammation (Inflammations)
06/2013 - 09/2008
5Atrophy
08/2012 - 07/2003
5Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
07/2010 - 04/2002
4Parkinsonian Disorders (Parkinsonism)
12/2021 - 04/2004
4Glioblastoma (Glioblastoma Multiforme)
03/2019 - 08/2003
4Lymphoma (Lymphomas)
04/2018 - 07/2005
4TDP-43 Proteinopathies
12/2015 - 03/2011
4Pick Disease of the Brain (Pick's Disease)
02/2014 - 11/2002
4Disease Progression
07/2013 - 03/2008
4Corticobasal Degeneration
07/2010 - 05/2002
4Nausea
01/2009 - 10/2002
3Virus Diseases (Viral Diseases)
01/2018 - 02/2004
3Huntington Disease (Huntington's Disease)
01/2018 - 12/2012
3Tuberous Sclerosis (Bourneville's Disease)
01/2018 - 05/2013
3Gliosis
04/2016 - 12/2009
3Multiple Sclerosis
04/2016 - 09/2009
3Proteostasis Deficiencies
01/2016 - 08/2012
3Sarcoma (Soft Tissue Sarcoma)
01/2016 - 12/2013
3Vasculitis (Vasculitides)
02/2014 - 12/2002
3Hypersensitivity (Allergy)
12/2013 - 11/2011
3Atopic Dermatitis (Atopic Eczema)
01/2013 - 11/2011
3Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
08/2012 - 04/2007

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2002
22alpha-SynucleinIBA
08/2010 - 02/2002
19polyglutamineIBA
01/2018 - 11/2002
15AntibodiesIBA
01/2016 - 02/2002
14UbiquitinIBA
02/2014 - 12/2002
12SynucleinsIBA
11/2019 - 02/2002
12DNA-Binding Proteins (DNA Binding Protein)IBA
01/2017 - 05/2007
10DNA (Deoxyribonucleic Acid)IBA
08/2015 - 02/2004
9Milnacipran (Ixel)FDA Link
01/2009 - 09/2003
8Messenger RNA (mRNA)IBA
01/2021 - 07/2003
7Dopamine (Intropin)FDA LinkGeneric
01/2018 - 08/2002
7Serotonin (5 Hydroxytryptamine)IBA
01/2017 - 10/2002
73-Iodobenzylguanidine (Iobenguane)IBA
09/2015 - 11/2004
7Fluvoxamine (Luvox)FDA LinkGeneric
06/2008 - 01/2002
6EnzymesIBA
01/2018 - 06/2003
6Amyloid beta-PeptidesIBA
10/2017 - 06/2002
6GliadinIBA
10/2016 - 12/2009
5RNA (Ribonucleic Acid)IBA
01/2021 - 09/2013
5Antidepressive Agents (Antidepressants)IBA
01/2017 - 02/2002
5AllergensIBA
10/2016 - 12/2009
5Amyloid (Amyloid Fibrils)IBA
08/2015 - 06/2002
5Immunoglobulin E (IgE)IBA
12/2013 - 12/2009
5Antipsychotic Agents (Antipsychotics)IBA
04/2010 - 08/2002
5Risperidone (Risperdal Consta)FDA LinkGeneric
10/2006 - 03/2002
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2019 - 11/2014
4Peptides (Polypeptides)IBA
01/2018 - 12/2002
4SteroidsIBA
08/2016 - 10/2004
4Codon (Codons)IBA
01/2016 - 11/2007
4Biomarkers (Surrogate Marker)IBA
09/2015 - 01/2007
4Mucin-1 (CA 15-3 Antigen)IBA
08/2014 - 12/2007
3Neuregulin-1 (Neuregulin 1)IBA
09/2022 - 06/2009
3Epidermal Growth Factor (EGF)IBA
09/2022 - 05/2005
3Pharmaceutical PreparationsIBA
12/2021 - 09/2004
3LigandsIBA
04/2018 - 06/2004
3Carrier Proteins (Binding Protein)IBA
01/2018 - 07/2006
3Glycoproteins (Glycoprotein)IBA
01/2017 - 11/2005
3ParaffinIBA
12/2016 - 12/2014
3Superoxide DismutaseIBA
01/2016 - 09/2008
3Immunoglobulin G (IgG)IBA
11/2015 - 10/2004
3TubulinIBA
09/2014 - 05/2010
3Protein Isoforms (Isoforms)IBA
08/2014 - 04/2004
3Peptide Hydrolases (Proteases)FDA Link
02/2014 - 12/2009
3Nuclear Proteins (Protein, Nuclear)IBA
02/2014 - 08/2008
3Superoxide Dismutase-1IBA
07/2013 - 10/2004
3AntigensIBA
01/2012 - 12/2009
3Endopeptidase K (Proteinase K)IBA
10/2011 - 08/2010
3Apolipoproteins E (ApoE)IBA
06/2011 - 07/2006
3Neurofilament ProteinsIBA
08/2010 - 12/2007
3Olanzapine (Zyprexa)FDA Link
04/2008 - 08/2006

Therapy/Procedure

11Therapeutics
08/2016 - 06/2002
5Drug Therapy (Chemotherapy)
11/2015 - 01/2003
4Ligation
01/2015 - 12/2002
4Punctures
01/2015 - 12/2002
3Radiotherapy
08/2016 - 01/2003
3Sympathectomy (Sympathectomies)
11/2008 - 06/2005